-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOXCEL THERAPEUTICS ANNOUNCES LAST PATIENT LAST VISIT IN SERENITY AT-HOME PIVOTAL PHASE 3 SAFETY TRIAL FOR ACUTE TREATMENT OF AGITATION ASSOCIATED WITH BIPOLAR DISORDERS OR SCHIZOPHRENIA

Reuters·08/01/2025 11:00:00

Please log in to view news